Bausch & Lomb Corp
BLCO: XTSE (CAN)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
CAD 88.00 | Mhgcgzc | Phdjjffk |
Bausch & Lomb Is Ramping Up Research and Development To Increase Competitive Positioning
Business Strategy and Outlook
As a new public company, Bausch & Lomb will be primarily focused on ramping up research and development to become more competitive in its key markets of contact lens and solution, eyecare surgery, and ophthalmic pharmaceuticals.